SCHEMBL369175

SCHEMBL369175

Nc1ccc(-c2ccc(N(N)N)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.61
CYP3A4 P08684 7/20 0.61
TDP1 Q9NUW8 5/20 0.61
TP53 P04637 3/20 0.61
HSD17B10 Q99714 4/20 0.50
TAAR1 Q96RJ0 3/20 0.50
ALOX15 P16050 4/20 0.48
MAPK1 P28482 3/20 0.48
MAPT P10636 4/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
KDM4E B2RXH2 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
KIF11 P52732 1/20 0.42
PSMD14 O00487 1/20 0.42
TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9149010 0.91 CYP3A4 (0.55) ALDH1A1CYP3A4TDP1TP53HSD17B10
SCHEMBL4519085 0.88 CYP3A4 (0.39) ALDH1A1CYP3A4TDP1TP53HSD17B10
SCHEMBL4852052 0.80 ALDH1A1 (0.67) ALDH1A1CYP3A4TDP1TP53HSD17B10
Benzidine SCHEMBL720393 0.78 CYP3A4 (1.00) ALDH1A1CYP3A4TDP1TP53HSD17B10
Benzidine SCHEMBL5140469 0.78 CYP3A4 (1.00) ALDH1A1CYP3A4TDP1TP53HSD17B10
SCHEMBL258287 0.78 CYP3A4 (1.00) ALDH1A1CYP3A4TDP1TP53HSD17B10
SCHEMBL2024128 0.78 CYP3A4 (1.00) ALDH1A1CYP3A4TDP1TP53HSD17B10
Benzidine SCHEMBL29021 0.78 CYP3A4 (1.00) ALDH1A1CYP3A4TDP1TP53HSD17B10
SCHEMBL8663846 0.78 ALDH1A1 (0.50) ALDH1A1CYP3A4TDP1HSD17B10TAAR1
SCHEMBL7007088 0.76 ALDH1A1 (0.59) ALDH1A1CYP3A4TDP1TP53HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119365523-A Articles comprising a combination of polymer aerogel and melamine formaldehyde foam and related systems and methods 气凝胶科技有限责任公司 2025-01-24 CN disclosed
EP-2011885-B1 Method of diagnosing bladder cancer ONCOTHERAPY SCIENCE INC (JP) 2015-04-22 EP disclosed
US-20130011933-A1 METHOD OF DIAGNOSING BLADDER CANCER ONCOTHERAPY SCIENCE, INC. (JP) 2013-01-10 US disclosed
US-20120014996-A1 METHOD OF DIAGNOSING BLADDER CANCER ONCOTHERAPY SCIENCE, INC. (JP) 2012-01-19 US disclosed
US-7998695-B2 Method of diagnosing bladder cancer ONCOTHERAPY SCIENCE, INC. (JP) 2011-08-16 US disclosed
EP-2292796-A1 Method of diagnosing bladder cancer Oncotherapy Science, Inc. (JP) 2011-03-09 EP disclosed
US-20090175844-A1 METHOD OF DIAGNOSING BLADDER CANCER ONCOTHERAPY SCIENCE INC. (JP) 2009-07-09 US disclosed
EP-2059812-A1 METHODS OF SCREENING FOR AGENTS THAT INHIBIT BINDING BETWEEN MPHOSPH1 AND PRC1 Oncotherapy Science, Inc. (JP) 2009-05-20 EP disclosed
EP-2011885-A2 Method of diagnosing bladder cancer Oncotherapy Science, Inc. (JP) 2009-01-07 EP disclosed
WO-2008023842-A1 METHODS OF SCREENING FOR AGENTS THAT INHIBIT BINDING BETWEEN MPHOSPH1 AND PRC1 ONCOTHERAPY SCIENCE, INC. (JP) 2008-02-28 WO disclosed